Encephalomyocarditis virus vaccine

Details Encephalomyocarditis virus vaccine Encephalomyocarditis virus vaccine

1990-10-24

1993-05-25

Wityshyn, Michael G.

Drug, bio-affecting and body treating compositions

Lymphokine

424 88, 4352351, 435236, 435238, A61K 3912, C12N 700

Patent

active

052137953

ABSTRACT:
The present invention provides an inactivated encephalomyocarditis virus (EMCV) vaccine produced from swine isolates which protects swine from diseases caused by EMCV. The vaccine is produced from swine isolates and protects against respiratory problems, myocardial and pulmonary inflammation and necrosis, and confers protection against reproductive disorders resulting from some strains of the virus.

REFERENCES:
Bogaerts et al., Infection and Immunity, vol. 6, pp. 508-512, 1972.
Acland et al., The Iowa State University Press, Dunne et al., Ed. pp. 339-343, 1981.
Matsumori et al., Biological Abstracts, vol. 85, (5), Ref. No. 48849, 1987.
Kim et al., Arch. Virol. vol. 109, pp. 51-57, 1989.
Boulton, J., (1987), Can. Vet. J., 28:713.
Littlejohns, I., Aust. Vetern. J. 61:93 (1984).
Norkiss, A., et al. (1982), New Eng. J. Med. 306:486.
Successful Farming (1989) 87:112.
National Hog Farmer (Nov. 1989).

Affiliated with

Also associated with

Rating

Encephalomyocarditis virus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Encephalomyocarditis virus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Encephalomyocarditis virus vaccine will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-895944